Search
Thursday 23 April 2015
  • :
  • :

Investor’s Watch List - Matador Resources (NYSE:MTDR), Zogenix, (NASDAQ:ZGNX), Yamana Gold (NYSE:AUY), LinnCo (NASDAQ:LNCO)

In the course of current trading session Following Stocks are among the “Top Priority Stocks” For Traders: Matador Resources (NYSE:MTDR), Zogenix, (NASDAQ:ZGNX), Yamana Gold (NYSE:AUY), LinnCo (NASDAQ:LNCO)

Their insights are depicted underneath:

Matador Resources Co (NYSE:MTDR), shares picked up 2.43%, and is now trading at $20.63. The stock volatility for the week is 4.93%, while for the month remained 4.56%. The company holds consensus target price of $27.00.

If we consider EPS growth of the company, then the company indicated the following observations:

The company showed 1.54 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained 102.60% and Annual EPS growth for the past 5 years is considered as 50.70%.

The mean recommendation of analysts for this stock is 1.90. (Where 1=Buy, 5=Sale).

Matador Resources Co (MTDR), an independent energy company, engages in the exploration, development, production, and acquisition of oil and natural gas resources in the United States. The company primarily holds interests in the Eagle Ford shale play in South Texas; the Wolfcamp and Bone Spring plays in the Permian Basin in Southeast New Mexico and West Texas; and the Haynesville shale and Cotton Valley plays in Northwest Louisiana and East Texas.

Zogenix, Inc. (NASDAQ:ZGNX), declined -1.44%, and is now trading at $1.37. The stock has price to sale ratio of 5.26, however, price to book ratio is 3.76. With recent decline, the year-to-date (YTD) performance reflected a 1.49% incline. During the past month the stock lost -12.58%, bringing three-month performance to 19.83% and six-month performance to 16.81%. The mean recommendation of analysts for this stock is 1.40 (where 1=Buy, 5=Sale).

Zogenix, Inc. (ZGNX), a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States. Its marketed product includes Zohydro ER, an extended-release formulation of hydrocodone for the treatment of severe chronic pain.

Yamana Gold Inc. (USA) (NYSE:AUY), declined -1.32%, and is now trading at $4.11. The company holds the market capitalization of $3.90B. For the last twelve months, the stock was able to keep return on equity at -33.50%, while return on assets at –19.40%, in response to its return on investment at -13.30%. Its 20-day moving average gained 6.21%, below 50-day moving average of 1.59%, above 200-day moving average of -28.51% from the latest market price of $4.11. The mean recommendation of analysts for this stock is 2.50. (Where 1=Buy, 5=Sale).

Yamana Gold Inc. (USA) (AUY), is engaged in gold mining and related activities, including exploration, extraction, processing, and reclamation. The company has precious metal properties and land positions throughout the Americas, including in Brazil, Chile, Argentina, and Mexico. Its portfolio includes seven operating gold mines, such as Chapada (copper/gold), El Peñón (gold/silver), Jacobina, Gualcamayo, Minera Florida (gold/silver/zinc), Fazenda Brasileiro, and Mercedes (gold/silver), as well as a 12.5% indirect interest in the Alumbrera mine (copper/gold/molybdenum); and various development stage projects and exploration properties in Brazil, Chile, Argentina, and Mexico.

LinnCo LLC (NASDAQ:LNCO), rose 0.39%, and is now trading at $10.19. Its volatility for the week is 5.42%, while for the month it is 4.36%. The company has the market capitalization of $1.30B. The company holds the book value per share of 10.10, whereas cash per share is 0.05. Price to book ratio remained 1.00. Analysts mean recommendation for the stock is said to be 2.50. (where 1=Buy, 5=sale).

LinnCo LLC (LNCO), through its limited liability company interests in Linn Energy, LLC, focuses on the acquisition and development of oil and natural gas properties in the United States. The company was founded in 2012 and is headquartered in Houston, Texas.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *